<--- Back to Details
First PageDocument Content
Biosimilar / Biotechnology / Drugs / Intas Biopharmaceuticals / Biologic / Pharmaceutical industry in India / Quintiles / Pharmaceutical industry / Pharmacy school / Pharmacology / Pharmaceutical sciences / Clinical research
Date: 2014-10-15 07:40:23
Biosimilar
Biotechnology
Drugs
Intas Biopharmaceuticals
Biologic
Pharmaceutical industry in India
Quintiles
Pharmaceutical industry
Pharmacy school
Pharmacology
Pharmaceutical sciences
Clinical research

Oct 27-29, 2014 Nigel Rulewski TENTATIVE SCIENTIFIC PROGRAM Eminent Speakers

Add to Reading List

Source URL: www.pharmaceuticalconferences.com

Download Document from Source Website

File Size: 380,65 KB

Share Document on Facebook

Similar Documents

CNX Nifty / Science and technology in Israel / Teva Pharmaceutical Industries / Mylan / Intas Biopharmaceuticals / Ranbaxy Laboratories / PVT

REGISTER FOR APPROVED HUMAN MEDICINES JUNE 2016 UPDATE GENERIC NAME FORM DEXTROSE MONOHYDRATE OR ANHYDROUS INFUSIONS

DocID: 1ppk7 - View Document

Biosimilar / Biotechnology / Drugs / Intas Biopharmaceuticals / Biologic / Pharmaceutical industry in India / Quintiles / Pharmaceutical industry / Pharmacy school / Pharmacology / Pharmaceutical sciences / Clinical research

Oct 27-29, 2014 Nigel Rulewski TENTATIVE SCIENTIFIC PROGRAM Eminent Speakers

DocID: HnQg - View Document

Pharmaceutical industry / Food and Drug Administration / Pharmaceuticals policy / Biosimilar / Intas Biopharmaceuticals / Biologic / Hospira / Clinical trial / Reliance Life Sciences / Pharmaceutical sciences / Pharmacology / Clinical research

Article Current regulations governing biosimilars

DocID: 25Gi - View Document

Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / GlaxoSmithKline / Generic drug / Pfizer / Food and Drug Administration / Intas Biopharmaceuticals / Pharmaceutical sciences / Pharmacology / Health

PDF Document

DocID: 1nuZ - View Document